All abstracts should be submitted electronically through the abstract submission system.
Abstract submission is open from 15 January 2020 to 29 February 2020. The deadline for the submission is 29 February 2020, 11:59 p.m. CET. Abstracts received after closing of the abstract system will not be accepted.
By submitting the abstract you agree and confirm that:
if the abstract is accepted, you will attend the EUPHA section Health Workforce Research (HWR) Section Mid-term Conference. To confirm your attendance, you have to register for the conference by 15th of May 2020.
If you have not registered by that date your abstract will be removed from the conference programme.
Please note, when choosing a bank transfer for the conference fee we have to receive your payment by 1st of June.
You are responsible for ensuring that all co-authors have agreed to be listed on the abstract.
Each main author may submit maximum 2 abstracts.
Your abstract will not be edited. You are responsible for any spelling, grammatical and typographical errors.
All abstracts must be submitted and, if accepted, presented in English.
All abstracts have a limit of 2,000 characters, including spaces but excluding title and authors’ information. If you exceed the character limit, the system will not accept the abstract.
Graphics or tables cannot be accepted.
Abstract titles should be in lower case, except the first word, abbreviations and countries. Do not use capital letters only and avoid using abbreviations or acronyms. Give geographic location and dates if applicable.
Author and co-author: you can include up to 10 co-authors. Please follow the instructions carefully and make sure that initials, last name, department, institution, town and country are completed. Please make sure that you use the English version of the institute, town and country. Spell out the full name of the institution and do not use abbreviations such as ‘Univ.’ for ‘University’. Please make sure that the presenting author is also listed under authors.
Address the scientific background and rationale for the study as well as the public health significance of the subject. Explain why your study is important and what question(s) it will answer.
Describe the study design, setting (such as community, clinic, hospital), study participants, analytic and/or intervention techniques and outcome measures.
Present the major quantitative and qualitative findings, accompanied by confidence intervals or levels of significance of statistical tests, as appropriate. Although negative as well as positive results may be of interest, report only those results that relate to your conclusion. Since an abstract may be cited, this section must contain data rather than a statement like “Data will be discussed”. If appropriate, state that the results are preliminary.
State only those conclusions that are directly supported by data. Report on the public health actions that are recommended and/or have been implemented as a consequence of the study such as:
a. initiating or enhancing prevention or other public health activities
b. developing procedure, policies or legislation
c. implementing and strengthening public health surveillance systems.
Highlight the magnitude of the public health impact by reporting on the process of output/outcome indicators (such as number of persons treated, amount of resources committed, evidence of improvements, changes in behaviour, etc.). Describe the ways in which the public health actions were innovative.
Write two short (200 characters maximum) messages which summarize the main impact of your work.
Please include 3 to 5 keywords.
Type of presentation
You should indicate your first and second presentation preference. The following possibilities are available:
Abstract submission deadline
29 February 2020
Abstracts will be scored independently by 3-4 experts and scored on the basis of the following criteria:
Notification of decision: 27 March 2020.